3Graham LA,Kenny RA.Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncope[ J ].Europace,2001,3(2):141-146.
4Graham LA,Kenny RA.Clinical characteristics of unexplained syncope and their relationship to tilt table test outcomes[ J ].Clin Auton Res,2002,12(2):88-93.
5Almquist A;Goldenbenberg IF;Milstein S.Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope,1989.
6Grubb BP;Temesy-Armos P;Moore J.The use of headupright tilt table testing in the evaluation and management of syncope in children and adolescents,1992.
7Ward CR;Gray JC;Gilroy JJ.Midodrine:A role in the management of neurocardiogenic syncope,1998.
8Morillo CA;Leitch JW;Yec R.A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt,1993.
9Grubb BP;Wolfe DA;Samoil D.Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope,1993(03).
10Atiga WL;Rowe P;Calking H.Management of vasovagal syncope[J],1999.
10Duygu H,Zoghi M,Turk R,et al.The role of tilt training in prevention recur-rent syncope in patientswith vasovagal syncope:a prospective and randomizedstudy[J].PACE,2008,31:592-596.
